Catherine Stehman-Breen

Insider Reports History

Entity
Individual
Location
215 First Street, Suite 415, Cambridge, Massachusetts
Signature
/s/ Shawna-Gay White, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Catherine Stehman-Breen:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Generation Bio Co. Director Stock Option (right to buy) 60K $275K $4.59 Jun 6, 2024 Direct
Tenaya Therapeutics, Inc. Director Stock Option (Right to buy) 29.5K Jun 9, 2023 Direct
Dyne Therapeutics, Inc. Director Stock option (right to buy) 25.1K May 22, 2024 Direct

Insider Reports Filed by Catherine Stehman-Breen

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GBIO Generation Bio Co. Jun 6, 2024 1 $0 4 Jun 10, 2024 Director
DYN Dyne Therapeutics, Inc. May 22, 2024 1 $0 4 May 24, 2024 Director
TNYA Tenaya Therapeutics, Inc. Jun 9, 2023 1 $0 4 Jun 12, 2023 Director
GBIO Generation Bio Co. Jun 8, 2023 1 $0 4 Jun 12, 2023 Director
DYN Dyne Therapeutics, Inc. May 24, 2023 1 $0 4 May 25, 2023 Director
DYN Dyne Therapeutics, Inc. Jul 5, 2022 1 $0 4 Jul 6, 2022 Director
TNYA Tenaya Therapeutics, Inc. Jun 10, 2022 1 $0 4 Jun 13, 2022 Director
GBIO Generation Bio Co. Jun 9, 2022 1 $0 4 Jun 13, 2022 Director
DYN Dyne Therapeutics, Inc. Jun 3, 2022 1 $0 4 Jun 6, 2022 Director
TNYA Tenaya Therapeutics, Inc. Jul 29, 2021 0 $0 3 Jul 29, 2021 Director
GBIO Generation Bio Co. Jun 9, 2021 1 $0 4 Jun 11, 2021 Director
DYN Dyne Therapeutics, Inc. May 26, 2021 1 $0 4 May 27, 2021 Director